Marko Spasić

8.5k citations
66 papers · 6.9k · 3 hit papers · h-index 17

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Pancreatic and Hepatic Oncology Research
  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune cells in cancer

Papers in

    • CAR-T cell therapy research 3
    • Intraperitoneal and Appendiceal Malignancies 4
    • Pancreatitis Pathology and Treatment 3

Marko Spasić

57 papers receiving 6.7k citations

Marko Spasić's Hit Papers

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial 2022 · 273 citations
2730+4+8Years since publication10002.0k3.0k4.0k5.0k

Peers

Marko Spasić
Comparison fields: 5 of 117
  • Oncology 4.5k
  • Immunology 3.3k
  • Cancer Research 472
  • Pulmonary and Respiratory Medicine 723
  • Genetics 172
Replace Riccardo Mezzadra with:
Riccardo Mezzadra United States
Liufu Deng China
Andrea Schietinger United States
Ravindra Uppaluri United States
Jillian L. Astarita United States
Beata Berent-Maoz United States
Shin Foong Ngiow United States
Shaun O’Brien United States
Arabella Young Australia
Nicole M. Haynes Australia
Marko Spasić relative to Riccardo Mezzadra United States Riccardo Mezzadra's profile →
Citations per field
00.5×2×4×6×8.9×
Riccardo Mezzadra · 1×
Citations per year

Countries citing papers authored by Marko Spasić

Since Specialization
Citations

This map shows the geographic impact of Marko Spasić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Spasić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Spasić more than expected).

Fields of papers citing papers by Marko Spasić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Spasić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Spasić. The network helps show where Marko Spasić may publish in the future.

Co-authors

The 25 scholars most cited alongside Marko Spasić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marko Spasić Line = papers co-authored together Marko Spasić links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.

#Work
1
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Hit paper breakdown →
20145527
2
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Hit paper breakdown →
2019510
3
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
Hit paper breakdown →
2022273
4 202348
5 201237
6 201129
7 201228
8 201628
9 201227
10 201227
11 201126
12 202323
13 201220
14 201520
15 202220
16 201619
17 201717
18 201616
19 201213
20 201313

About Marko Spasić

Marko Spasić is a scholar working on Oncology, Surgery, Genetics, Pulmonary and Respiratory Medicine and Neurology, having authored 66 papers that have together received 6.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Vestibular and auditory disorders (4 papers), Breast Lesions and Carcinomas (4 papers), Neurofibromatosis and Schwannoma Cases (4 papers), Meningioma and schwannoma management (4 papers), Intraperitoneal and Appendiceal Malignancies (4 papers), CAR-T cell therapy research (3 papers) and Pancreatitis Pathology and Treatment (3 papers). The work is most often cited by research in Oncology (4.5k citations), Immunology (3.3k citations), Cancer Research (472 citations), Pulmonary and Respiratory Medicine (723 citations) and Genetics (172 citations). Marko Spasić has collaborated with scholars based in Serbia, United States and Montenegro. Frequent co-authors include Isaac Yang, Daniel T. Nagasawa, Adriana M. Mujal, Jessica L. Tsui, Vincent Chan, Mikhail Binnewies, Jonathan P. Giurintano, Patrick K. Ha, Alexis J. Combes and Kelly Kersten. Their work appears in journals such as Neurosurgery Clinics of North America, Frontiers in Public Health, Cells, Clinical Neurology and Neurosurgery and Neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact